Method for in vitro assay of soluble fibrin by generating specific degradation products
US8883433B2 · kind B2 · utility
0Cited by
9References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 25, 2003 |
| Grant date | Nov 11, 2014 |
| Priority date | — |
| Expiry date | Feb 25, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q1/56
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention concerns a method for assaying soluble fibrin in a sample, in which said sample is brought into the presence of a plasminogen activator with a high specificity for soluble fibrin (PA-Fb sp) and the soluble fibrin count in the sample is measured by measuring the difference between the count of fibrin degradation products obtained after degrading soluble fibrin with PA-Fb sp and the base count of fibrin degradation products determined before bringing the sample into the presence of PA-Fb sp.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.